• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Projects
  • Funding
  • Research Data
  • Organizations
  • Researchers
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial.
 

Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial.

Options
  • Details
BORIS DOI
10.48350/177355
Date of Publication
March 2023
Publication Type
Article
Division/Institute

Universitätsklinik fü...

Contributor
Zander, Thilo
Pabst, Thomas Niklaus
Universitätsklinik für Medizinische Onkologie
Schär, Sämi
Aebi, Stefan
Mey, Ulrich
Novak, Urban
Universitätsklinik für Medizinische Onkologie
Lerch, Erika
Rhyner Agocs, Gaëlle
Goede, Jeroen
Maniecka, Zuzanna
Hayoz, Stefanie
Rüfer, Axel
Renner, Christoph
Driessen, Christoph
Subject(s)

600 - Technology::610...

Series
Leukemia
ISSN or ISBN (if monograph)
1476-5551
Publisher
Springer Nature
Language
English
Publisher DOI
10.1038/s41375-023-01809-z
PubMed ID
36635391
Handle
https://boris-portal.unibe.ch/handle/20.500.12422/120489
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
s41375-023-01809-z.pdftextAdobe PDF410.29 KBAttribution (CC BY 4.0)publishedOpen
BORIS Portal
Bern Open Repository and Information System
Build: 396f6f [24.09. 11:22]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo